Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Champions Oncolog (NQ: CSBR )

4.055 +0.045 (+1.13%)
Streaming Delayed Price Updated: 11:08 AM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,504
Open 4.055
Bid (Size) 4.000 (1)
Ask (Size) 4.080 (1)
Prev. Close 4.010
Today's Range 4.055 - 4.055
52wk Range 3.750 - 9.880
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Champions Oncology Reports Quarterly Revenue of $12.8 Million
Via ACCESSWIRE
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga

Performance

YTD
-8.25%
-8.25%
1 Month
-5.30%
-5.30%
3 Month
-0.36%
-0.36%
6 Month
-55.53%
-55.53%
1 Year
-52.07%
-52.07%

More News

Read More
Champions Oncology's Earnings: A Preview
Via Benzinga
Champions Oncology's Return On Capital Employed Insights
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $12.9 Million
Via ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023
Via ACCESSWIRE
Analyzing Champions Oncology's Short Interest
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
Via ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
Via ACCESSWIRE
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
Via Benzinga
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
Via ACCESSWIRE
Earnings Scheduled For September 8, 2022
Via Benzinga
Earnings Preview For Champions Oncology
Via Benzinga
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
From Champions Oncology, Inc.
Via AccessWire
A Preview Of Champions Oncology's Earnings
Via Benzinga
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
From Champions Oncology, Inc.
Via AccessWire
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
From Champions Oncology, Inc.
Via AccessWire
Earnings Scheduled For July 21, 2022
Via Benzinga
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
From Champions Oncology, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here's How Much You Would Have Made Owning Champions Oncology Stock In The Last 5 Years
Via Benzinga
Champions Oncology Earnings Perspective: Return On Capital Employed
Via Benzinga
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
From Champions Oncology, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.